MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation PEG 2011-2026 | BPMC
PEG Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -120 | -37.8 | -0.516 | -2.75 | 5.15 | 0.253 | 0.35 | 0.426 | -0.899 | 0.285 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.15 | -120 | -15.5 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | USA |
 |
Lipocine
LPCN
|
0.000978 | $ 7.4 | 1.23 % | $ 39 M | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-0.767 | $ 217.23 | -0.38 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 19.47 | 1.25 % | $ 910 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 8.28 | -1.84 % | $ 110 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
0.105 | $ 1.68 | 2.13 % | $ 610 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
0.158 | $ 0.74 | 21.89 % | $ 8.48 M |  Israel |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Exelixis
EXEL
|
-2.14 | $ 41.51 | 0.23 % | $ 11.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.36 | -3.21 % | $ 347 M | Britain |
 |
MediWound Ltd.
MDWD
|
0.0499 | $ 16.64 | -1.42 % | $ 453 M | Israel |
 |
Mesoblast Limited
MESO
|
1.3 | $ 14.31 | 2.07 % | $ 9.29 B |  Australia |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
ChemoCentryx
CCXI
|
-0 | - | - | $ 3.74 B | USA |
 |
Genmab A/S
GMAB
|
0.277 | $ 25.73 | 0.19 % | $ 16.5 B | Danmark |
 |
Aytu BioScience
AYTU
|
-0.00324 | $ 2.61 | -0.76 % | $ 16.4 M | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Immatics N.V.
IMTX
|
2.14 K | $ 9.19 | -3.36 % | $ 578 M | Germany |
 |
Bellerophon Therapeutics
BLPH
|
0.0308 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
1.34 | $ 4.34 | -1.92 % | $ 832 M | Canada |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
-0.108 | $ 69.55 | -1.75 % | $ 11.1 B | USA |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |
 |
Brickell Biotech
BBI
|
-0.00369 | - | -5.38 % | $ 6.06 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | USA |